{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:34:21Z","timestamp":1790354061564,"version":"4.1.0"},"reference-count":46,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2025,4,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>\n              Febrile neutropenia (FN) is a serious complication in patients with hematologic malignancies following treatments such as chemotherapy and hematopoietic stem cell transplantation. It is typically managed with broad-spectrum antibiotics (BSA), but the optimal duration of BSA therapy remains controversial. This meta-analysis aimed to assess the clinical efficacy and safety of early antibiotic de-escalation in patients with hematologic malignancies with FN before hematopoietic recovery, compared to those who continued BSA until hematopoietic recovery. Statistical analysis included pooled odds ratios (OR) for mortality and secondary adverse outcomes, along with subgroup analysis to identify patient populations that may benefit from early de-escalation. Ten studies, mostly retrospective observational designs, were included. Early de-escalation significantly reduced mortality risk (OR 0.20, 95% CI 0.06\u20130.69). Subgroup analyses showed mortality benefits in older patients (&gt;55 years old, OR 0.42, 95% CI 0.18\u20130.98) and in higher-quality studies (OR 0.07, 95% CI 0.01\u20130.62). No significant differences were observed for infection-related ICU admissions, bacteremia, recurrent fever, or\n              <jats:italic>Clostridium difficile<\/jats:italic>\n              infection (CDI). In conclusion, early de-escalation of BSA in patients with hematologic malignancies and developing FN after treatment significantly reduces mortality risk without increasing major adverse events. These findings support the use of early de-escalation and highlight the need for personalized strategies to improve patient outcomes.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/aac.01597-24","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:01:05Z","timestamp":1741870865000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis"],"prefix":"10.1128","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9170-7439","authenticated-orcid":false,"given":"Yu-Han","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Englewood Hospital and Medical Center","place":["Englewood, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6796-3407","authenticated-orcid":false,"given":"Andrea Yue-En","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Medicine, National Yang Ming Chiao Tung University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3703-8865","authenticated-orcid":false,"given":"Karishma","family":"Narain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Englewood Hospital and Medical Center","place":["Englewood, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Cheng","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Taoyuan General Hospital, Ministry of Health and Welfare","place":["Taoyuan, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh","family":"Yang","sequence":"additional","affiliation":[{"name":"Jacob\u2019s School of Medicine and Biomedical Sciences, State University of New York at Buffalo","place":["Buffalo, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Huang","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jie","family":"Jhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Changhua Christian Hospital","place":["Changhua, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shen","family":"Dai","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Rastogi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Englewood Hospital and Medical Center","place":["Englewood, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6061-5168","authenticated-orcid":true,"given":"Cho-Hao","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702503"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2010.01.010"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-017-1016-1"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061501"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2014.01.008"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01328-4"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac074"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq147"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00269"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw325"},{"key":"e_1_3_4_12_2","unstructured":"Anonymous. 2024. Prevention and treatment of cancer-related infections Version 12024. Available from: https:\/\/wwwnccnorg\/guidelines\/category_1"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.091025"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/20499361221138346"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181de0c26"},{"key":"e_1_3_4_16_2","unstructured":"Anonymous. 2024. World health organization. The evolving threat of antimicrobial resistance: options for action world health organization. Available from: https:\/\/iriswhoint\/handle\/10665\/44812"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1608"},{"key":"e_1_3_4_19_2","first-page":"989","article-title":"Neutropenic fever in patients after high-dose chemotherapy followed by autologous haematopoietic progenitor cell transplantation and human recombinant granulocyte-macrophage colony stimulating factor","volume":"14","author":"Gl\u00fcck S","year":"1994","unstructured":"Gl\u00fcck S, Gagnon A. 1994. Neutropenic fever in patients after high-dose chemotherapy followed by autologous haematopoietic progenitor cell transplantation and human recombinant granulocyte-macrophage colony stimulating factor. Bone Marrow Transplant 14:989\u2013990.","journal-title":"Bone Marrow Transplant"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019890886"},{"key":"e_1_3_4_21_2","unstructured":"Anonymous. 2024. Preferred reporting items for systematic reviews and meta-analyses (PRISMA). Available from: https:\/\/wwwprisma-statementorg"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.12"},{"key":"e_1_3_4_25_2","unstructured":"Anonymous. 2023. The cochrane collaboration cochrane handbook for systematic reviews of interventions. Available from: https:\/\/trainingcochraneorg\/handbook\/current"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.17085\/apm.21038"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341x.2000.00455.x"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155219865303"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa138"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04132-0"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx226"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab624"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/10781552211067776"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.7054"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.18683\/germs.2023.1388"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.03.018"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30211-9"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.07.002"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/107327481702400212"},{"key":"e_1_3_4_42_2","volume-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","author":"John EB","year":"2024","unstructured":"JohnEB, Raphael D, MartinJB. 2024. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. 8th ed. Elsevier, Philadelphia, US.","edition":"8"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ1199"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/0885066618762747"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.006"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.37201\/req\/s03.06.2022"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2014.09.011"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01597-24","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01597-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:35:49Z","timestamp":1743744949000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01597-24"}},"subtitle":[],"editor":[{"given":"Pranita D.","family":"Tamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,2]]}},"alternative-id":["10.1128\/aac.01597-24"],"URL":"https:\/\/doi.org\/10.1128\/aac.01597-24","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"2024-10-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01597-24"}}